Infliximab versus ciclosporin in severe ulcerative colitis

被引：6
|
作者：
Levesque, Barrett G. [1 ]
Sandborn, William J. [1 ]
机构：
[1] Univ Calif San Diego, Div Gastroenterol, Ctr Inflammatory Bowel Dis, La Jolla, CA 92093 USA
来源：
LANCET | 2012年 / 380卷 / 9857期
关键词：
INTRAVENOUS CYCLOSPORINE; THERAPY; INDUCTION;
D O I：
10.1016/S0140-6736(12)61259-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1887 / 1888
页数：2
相关论文
共 50 条
  • [1] Infliximab or ciclosporin for acute severe ulcerative colitis?
    Ananthakrishnan, Ashwin N.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (01) : 2 - 3
  • [2] Steroid-refractory ulcerative colitis-ciclosporin or infliximab?
    Kaur, Manreet
    Targan, Stephen R.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (01) : 8 - 9
  • [3] Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
    Laharie, David
    Bourreille, Arnaud
    Branche, Julien
    Allez, Matthieu
    Bouhnik, Yoram
    Filippi, Jerome
    Zerbib, Frank
    Savoye, Guillaume
    Nachury, Maria
    Moreau, Jacques
    Delchier, Jean-Charles
    Cosnes, Jacques
    Ricart, Elena
    Dewit, Olivier
    Lopez-Sanroman, Antonio
    Dupas, Jean-Louis
    Carbonnel, Franck
    Bommelaer, Gilles
    Coffin, Benoit
    Roblin, Xavier
    Van Assche, Gert
    Esteve, Maria
    Farkkila, Martti
    Gisbert, Javier P.
    Marteau, Philippe
    Nahon, Stephane
    de Vos, Martine
    Franchimont, Denis
    Mary, Jean-Yves
    Colombel, Jean-Frederic
    Lemann, Marc
    LANCET, 2012, 380 (9857) : 1909 - 1915
  • [4] Length of hospital stay and associated hospital costs with infliximab versus cyclosporine in severe ulcerative colitis
    Loewenberg, Mark
    Duijvis, Nicolette W.
    Ponsioen, Cyriel
    van den Brink, Gijs R.
    Fockens, Paul
    D'Haens, Geert R. A. M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (11) : 1240 - 1246
  • [5] Infliximab or cyclosporine for acute severe ulcerative colitis: A retrospective analysis
    Dean, Kathryn E.
    Hikaka, Joanna
    Huakau, John T.
    Walmsley, Russell S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (03) : 487 - 492
  • [6] Commentary: predicting response to ciclosporin in acute severe ulcerative colitis
    Peake, S. T.
    Hart, A. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (11-12) : 1095 - 1096
  • [7] Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial
    Williams, John G.
    Alam, M. Fasih
    Alrubaiy, Laith
    Arnott, Ian
    Clement, Clare
    Cohen, David
    Gordon, John N.
    Hawthorne, A. Barney
    Hilton, Mike
    Hutchings, Hayley A.
    Jawhari, Aida U.
    Longo, Mirella
    Mansfield, John
    Morgan, Jayne M.
    Rapport, Frances
    Seagrove, Anne C.
    Sebastian, Shaji
    Shaw, Ian
    Travis, Simon P. L.
    Watkins, Alan
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (01): : 15 - 24
  • [8] Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
    Garcia, Maria Jose
    Riestra, Sabino
    Amiot, Aurelien
    Julsgaard, Mette
    Garcia de la Filia, Irene
    Calafat, Margalida
    Aguas, Mariam
    de la Pena, Luisa
    Roig, Cristina
    Caballol, Berta
    Casanova, Maria Jose
    Farkas, Klaudia
    Boysen, Trine
    Bujanda, Luis
    Cuaran, Camila
    Dobru, Daniela
    Fousekis, Fotios
    Gargallo-Puyuelo, Carla Jerusalen
    Savarino, Edoardo
    Calvet, Xavier
    Huguet, Jose Maria
    Kupcinskas, Limas
    Lopez-Cardona, Julia
    Raine, Tim
    van Oostrom, Joep
    Gisbert, Javier P.
    Chaparro, Maria
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (10) : 1248 - 1259
  • [9] Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis
    Ungar, B.
    Mazor, Y.
    Weisshof, R.
    Yanai, H.
    Ron, Y.
    Goren, I.
    Waizbard, A.
    Yavzori, M.
    Fudim, E.
    Picard, O.
    Loebstein, R.
    Kopylov, U.
    Dotan, I.
    Chowers, Y.
    Eliakim, R.
    Ben-Horin, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (12) : 1293 - 1299
  • [10] Letter: dose optimising infliximab in acute severe ulcerative colitis
    Choy, M. C.
    De Cruz, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (08) : 1169 - 1170
12345